I think losing the US market means it's more likely that a European based BP buys the company. (if JT is willing to sell and if hopefully CBB's source is accurate).
At this point I just would like a decent ROI of $10-15 a share. My dreams of $40 are long gone and $20 is just a mirage.
What a cluster after so much work to get this drug to market.